Company Data
Ainos Inc.
Ticker
AIMD
Current Price
$0.6321 -4.23%
Market Cap
$8.7M
Price Target
Refer to Report
Volume
279.7K
52wk Range
$0.4 - $3.1
Overview
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low dose oral form.